序贯四通道NMES对比传统两通道NMES治疗吞咽障碍的临床疗效:前瞻性双盲随机对照研究
本研究为前瞻性随机对照研究,纳入26例吞咽障碍患者,比较序贯四通道NMES与传统两通道NMES的康复效果。结果显示四通道组在VDS(口腔、咽部及总分)、PAS、FOIS及MDADI多个子集上较治疗前显著改善;两通道组仅VDS(口腔、咽部及总分)和MDADI(情感及身体子集)显著改善;组间直接比较显示四通道组在VDS口腔分及总分上改善更显著。
要点
- 序贯四通道NMES可显著改善吞咽障碍患者VDS口腔、咽部及总分、PAS、FOIS和MDADI多个子集。
- 两通道NMES组仅VDS(口腔、咽部及总分)和MDADI(情感及身体子集)较治疗前显著改善。
- 组间比较显示四通道NMES在VDS口腔分及总分上优于两通道NMES。
核心结论
- 序贯四通道NMES通过模拟吞咽相关肌肉的生理性激活顺序,可能成为吞咽障碍的新有效治疗方法。
研究设计与样本
- 干预为2-3周NMES治疗,最少7次,治疗时长300-800分钟。
主要发现
- 四通道NMES组VDS(口腔、咽部及总分)、PAS、FOIS及MDADI(情感、功能及身体子集)较治疗前显著改善。
- 两通道NMES组VDS(口腔、咽部及总分)和MDADI(情感及身体子集)显著改善,但PAS和FOIS未显著改善。
- 两组直接比较,四通道NMES组VDS口腔分及总分改善显著。
关键数值与推荐
- 评估工具包括视频透视吞咽障碍量表(VDS)、渗透-误吸量表(PAS)、MD Anderson吞咽障碍量表(MDADI)、功能性经口摄食量表(FOIS)及Likert量表。
临床怎么用
- 对吞咽障碍患者可考虑使用序贯四通道NMES,以期在VDS口腔分及总分等方面获得更明显改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To date, conventional swallowing therapies and 2-channel neuromuscular electrical stimulation (NMES) are standard treatments for dysphagia. The precise mechanism of 2-channel NMES treatment has not been determined, and there are controversies regarding the efficacy of this therapy. The sequential 4-channel NMES was recently developed and its action is based on the normal contractile sequence of swallowing-related muscles. OBJECTIVE: To evaluate and compare the rehabilitative effectiveness of the sequential 4-channel NMES with that of conventional 2-channel NMES. METHODS: In this prospective randomized case-control study, 26 subjects with dysphagia were enrolled. All participants received 2- or 4-channel NMES for 2-3 weeks (minimal session: 7 times, treatment duration: 300-800 min). Twelve subjects in the 4-channel NMES group and eleven subjects in the 2-channel NMES group completed the intervention. Initial and follow-up evaluations were performed using the videofluoroscopic dysphagia scale (VDS), the penetration-aspiration scale (PAS), the MD Anderson dysphagia inventory (MDADI), the functional oral intake scale (FOIS), and the Likert scale. RESULTS: The sequential 4-channel NMES group experienced significant improvement in their VDS (oral, pharyngeal, and total), PAS, FOIS, and MDADI (emotional, functional, and physical subsets) scores, based on their pretreatment data. VDS (oral, pharyngeal, and total) and MDADI (emotional and physical subsets) scores, but not PAS and FOIS scores, significantly improved in the 2-channel NMES group posttreatment. When the two groups were directly compared, the 4-channel NMES group showed significant improvement in oral and total VDS scores. CONCLUSIONS: The sequential 4-channel NMES, through its activation of the suprahyoid and thyrohyoid muscles, and other infrahyoid muscles mimicking physiological activation, may be a new effective treatment for dysphagia. TRIAL REGISTRATION: clinicaltrial.gov, registration number: NCT03670498, registered 13 September 2018, https://clinicaltrials.gov/ct2/show/NCT03670498?term=NCT03670498&draw=2&rank=1 .
引用
- Seo KH, Jang J, Jang EG, et al. Clinical effectiveness of the sequential 4-channel NMES compared with that of the conventional 2-channel NMES for the treatment of dysphagia in a prospective double-blind randomized controlled study. J Neuroeng Rehabil. 2021. PMID: 34059092. doi:10.1186/s12984-021-00884-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。